Skip to main content

Table 1 Binding energies, amino acid residues, binding distances and types of interaction among ligand and protein molecules

From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Name of protein (receptor)

PDB ID

Ligand

Binding energy ΔG

Amino acid residues

Distances A°

Type of interaction

Human

Caspase-I

6BZ9

VC

− 7.2 kcal/mol

LYS A:134

2.90

Conventional H-Bond

CYS A: 136

3.99

Pi-alkyl

VAL A: 133

4.20

Pi-alkyl

ILE A: 152

5.10

Pi-alkyl

TYR A: 153

4.75

Vander Waal

LEU A: 196

3.40

Vander Waal

LEU A: 196

5.44

Pi-Alkyl

LEU A: 135

5.48

Alkyl

ARG A: 163

4.86

Vander Waal

Human

COX-II

1CX2

VC

− 8.0 kcal/mol

GLN A: 192

3.79

C–H bond

GLY A: 354

3.73

C–H bond

HIS A: 351

3.59

C–H bond

HIS A: 356

4.55, 3.85

Pi-Cation

GLU A: 281

3.31

C–H bond

HIS A: 356, LYS A: 97

5.60, 5.24

Unfavourable cationic-cationic

Human

NFkB

1A3Q

VC

− 8.1

kcal/mol

ASP A: 319

4.10

Pi-anion

ASP A: 319

5.34

C–H bond

LYS A: 229

3.69

Pi-alkyl

GLU A: 71

3.54

C–H bond

ALA A: 68

5.38

Pi-alkyl

Human

TNF-α

1CA4

VC

− 7.0

kcal/mol

ARG A: 363

3.23

H–bond

LYS A: 364

3.07

H–bond

LYS A: 364

5.13

Alkyl

TRP A: 356

3.14

H–bond

LYS A: 357

2.85

H–bond

ILE A: 376

4.98

Alkyl

ILE A: 373

5.31, 5.16

Alkyl

ILE A: 358

3.36

C–H bond